PYC pyc therapeutics limited

Ann: PK STUDY RESULTS MOVE RP11 CLOSER TO FIRST IN HUMAN TRIALS, page-100

  1. 6,827 Posts.
    lightbulb Created with Sketch. 383
    i dont think they have the cash to stump up another 30%. Not all of them. And there is the risk element, as those 5 names are already overweight +++ and no smart businessman would think that was smart. This could fail yet and then they’d be worthless.

    The more important fact is as they have 60% it stops a major coming in and getting the whole company for 8c as could be the case. Most of the names would want 30c Or more as time goes on from the discussions i have had.

    I have a few more than I should but have no reason to sell any anytime soon.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.15
Change
0.020(1.77%)
Mkt cap ! $670.7M
Open High Low Value Volume
$1.15 $1.18 $1.11 $172.3K 151.3K

Buyers (Bids)

No. Vol. Price($)
1 592 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 4211 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.